Craft

Ori Biotech

Total Funding

$39.4 M

Revenue

£145.1 K

FY, 2021

Ori Biotech Summary

Company Summary

Overview
Ori Biotech is a company providing a platform that enables patients access to cell and gene therapies. Its platform closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing. The company also provides cell and gene therapy (CGT) manufacturing services.
Type
Private
Status
Active
Founded
2015
HQ
London, GB | view all locations
Website
https://oribiotech.com
Cybersecurity rating
Sectors

Key People

  • Jason C. Foster

    Jason C. Foster, CEO, Executive Director

  • Stuart Milne
  • Lee Unroe
  • Barry Clare

    Barry Clare, Chairman of the Board

    LocationsView all

    2 locations detected

    • London, England HQ

      United Kingdom

      2 Royal College St

    • London, England

      United Kingdom

      Admirals Way

    Ori Biotech Financials

    Summary Financials

    Revenue (FY, 2021)
    £145.1K
    Gross profit (FY, 2021)
    (£11.3M)
    Net income (FY, 2021)
    (£12.5M)
    Cash (FY, 2021)
    £74.5M
    EBIT (FY, 2021)
    (£15.4M)

    Footer menu